Antengene Therapeutics Limited
4 clinical trials · Sponsor
◉ Watch Antengene Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors (NCT05205109) | Antengene Therapeutics Limited | 2022-06-07 |
| Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies (NCT04305249) | Antengene Therapeutics Limited | 2020-08-15 |
| A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT04281420) | Antengene Therapeutics Limited | 2020-04-13 |
| Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects (NCT03591965) | Antengene Therapeutics Limited | 2018-08-07 |
Track Antengene Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.